Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Skin Neoplasms 2Melanoma 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Turcot syndrome 1Solid Tumors 1Solid Tumor, Adult 1Rectal Neoplasms 1Radiation Pneumonitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1NSCLC 1Motor Activity 1Lung Neoplasms 1Locally Advanced Esophageal Squamous Cell Carcinoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1

Interventions

Etoposide 5Cyclophosphamide 5Vincristine 4Methotrexate 4Doxorubicin 4Cytarabine 4pegaspargase 3merphos 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Leucovorin 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Calcium Dobesilate 3venetoclax 2prednylidene 2exifone 2deltacortene 2calaspargase pegol 2azathiopurine 2Whole-Body Irradiation 2Thioguanine 2Tacrolimus 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Immune Checkpoint Inhibitors × Clear all
NCT07541755 2026-04-21

PD1-VEN-CAG

Fujian Medical University Union Hospital

Phase 3 Active not recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡